Xoma Shares Surge on Impressive Quarterly Earnings
Xoma Royalty Corporation delivered a powerful financial performance in the third quarter of 2025, significantly exceeding analyst forecasts with a ...
Tag: XOMA
Xoma’s Acquisition Bid Reaches Critical Juncture
The fate of Xoma Royalty's proposed acquisition of LAVA Therapeutics hangs in the balance as shareholders convene for a decisive ...
The Royalty Aggregator: Xoma’s Unique Path to Biotech Profits
While many biotech firms focus their energy on groundbreaking laboratory discoveries, Xoma Royalty has carved out a distinct and profitable ...
XOMA Corporation Expands Portfolio with Acquisition of DSUVIA
On January 18, 2024, XOMA Corporation made an exciting move to expand its commercial royalty and milestone portfolio. The company ...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
